选择性TYK2抑制,产前细胞诊断和生物标志物导向免疫疗法:扩大精准医学

Mahmoud A Elkhalifa1, Robert B Kargbo2

  • 1University of Pennsylvania, Philadelphia, Pennsylvania 19104-6323, United States.

PubMed
概括

精准医学中的选择性正在迅速发展. 在TYK2抑制剂和胎儿细胞诊断等领域的创新正在改善神经,瘤和生殖疾病的治疗方法.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K